Our primary focus, for both adolescents with scoliosis as well as adults is to reduce the likelihood of scoliosis progression. We manage scoliosis management via Schroth Therapy. Our primary focus for our patients, both adults is halted progression, for adolescents (AIS) we strive for curve reduction when possible. Fortunately, we have had incredible results with our patients in our clinical practice using the Schroth Best Practice® Program by Dr. Weiss. Just prior to updating, adding to and improving the original Schroth program he conducted a study where he matched two patient cohorts by age and gender to determine whether or not Schroth Therapy helped reduce the likelihood of progression. The two groups were compared using the universally accepted criterion for progression – an increase in Cobb angle of more than 5°. One group remained untreated while the others participated in the Schroth scoliosis inpatient program he spearheaded at the Asklepios Katharina-Schroth clinic at the time.
The untreated group progressed 1.5 to 2.9 times more than the group treated with Schroth exercise. This was despite the fact that the treated group included patients who had curvatures with a greater Cobb angle magnitude, on average, compared to the untreated group. This is notable since it is generally accepted that those with larger Cobb angles are more likely to progress. The results of this study underscores the case for Schroth therapy for halting scoliosis curve progression.
Weiss, HR. Weiss G, Petermann F. Incidence of curvature progression in idiopathic scoliosis patients treated with scoliosis in-patient rehabilitation (SIR): an age- and sex- matched controlled study. Pediatr Rehabi I, Jan-Marc;6(I):23-30,2003.